title: Effect of the RET Inhibitor Vandetanib in a Patient With RET Fusion-Positive Metastatic Non-Small-Cell Lung Cancer.
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX Gerald.Falchook@scresearch.net.
authors.forename: Gerald S
authors.initials: GS
authors.lastname: Falchook
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Nelson G
authors.initials: NG
authors.lastname: Ordóñez
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Christel C
authors.initials: CC
authors.lastname: Bastida
authors.affiliation: Foundation Medicine, Cambridge, MA.
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Stephens
authors.affiliation: Foundation Medicine, Cambridge, MA.
authors.forename: Vincent A
authors.initials: VA
authors.lastname: Miller
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Lindsay
authors.initials: L
authors.lastname: Gaido
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Tiffiny
authors.initials: T
authors.lastname: Jackson
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Daniel D
authors.initials: DD
authors.lastname: Karp
mesh_terms: D000328:Adult; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D003598:Cytoskeletal Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D009362:Neoplasm Metastasis; D015514:Oncogene Proteins, Fusion / Q000037:antagonists & inhibitors / Q000378:metabolism; D010880:Piperidines / Q000627:therapeutic use*; D051096:Proto-Oncogene Proteins c-ret / Q000037:antagonists & inhibitors* / Q000378:metabolism; D011799:Quinazolines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: C088832:CCDC6 protein, human; D003598:Cytoskeletal Proteins; D015514:Oncogene Proteins, Fusion; D010880:Piperidines; D011799:Quinazolines; D051096:Proto-Oncogene Proteins c-ret; C452423:vandetanib